- Exchange: OTC US
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Avantogen Oncology Inc+ Add to Watchlist
AVTO:US0.0100 USD 0.0066 194.12%
As of 20:10:00 ET on 07/21/2014.
Company Profile for Avantogen Oncology Inc (AVTO)
Avantogen Oncology, Inc. acquires and develops pharmaceutical compounds focused on the treatment of cancer. The Company has a portfolio of several compounds targeted against various cancers and cancer related diseases. Avantogen seeks to license the compounds at an early stage of development, and then develop and commercialize them by partnering with pharmaceutical companies.
Avantogen Oncology Inc
Key Executives for Avantogen Oncology Inc (AVTO)
|William J Ardrey IVChairman/CEO||Angela Bronow DavanzoCFO/Secretary|